Lacosamide

In the US, Lacosamide (lacosamide systemic) is a member of the drug class miscellaneous anticonvulsants and is used to treat Seizures.

US matches:

• Lacosamide


• Lacosamide Tablets


• Lacosamide Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N03AX18

CAS registry number (Chemical Abstracts Service)

0175481-36-4

Chemical Formula

C13-H18-N2-O3

Molecular Weight

250

Therapeutic Categories

Antiepileptic agent

Analgesic

Anticonvulsant agent

Chemical Names

(R)-2-(acetylamino)-N-benzyl-3-methoxypropanamid (IUPAC)

(+)-(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide

(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide (WHO)

Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)- (USAN)

Foreign Names

• Lacosamidum (Latin)
• Lacosamid (German)
• Lacosamide (French)
• Lacosamida (Spanish)

Generic Names

• Lacosamide (OS: USAN)
• ADD 243037 (IS)
• Erlosamide (IS)
• Harkoseride (IS)
• SPM 927 (IS: SchwarzPharma)

Brand Names

• Vimpat
  Schwarz, United States; UCB, Austria; UCB, Australia; UCB, Germany; UCB, Spain; UCB, France; UCB, Sweden; UCB, United States; UCB Pharma, United Kingdom; UCB-Pharma, Switzerland

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.